Skip to main content
Erschienen in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie 5/2010

01.05.2010 | Reports of Original Investigations

Hydroxyethyl starch 130/0.4 attenuates early hepatic damage in ischemia/reperfusion injury

verfasst von: Dora Catré, MS, Joaquim S. Viana, PhD, António M. Cabrita, PhD, Manuel Oliveira, MB, Andreia Felizes, MS, Maria F. Lopes, PhD

Erschienen in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie | Ausgabe 5/2010

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Ischemia/reperfusion injury (IRI) remains a clinical challenge. We tested the hypothesis that fluid therapy using hydroxyethyl starch (HES) 130/0.4 during the early phase of IRI in rat liver decreases markers of hepatic injury.

Methods

We induced liver IRI in three groups of rats anesthetized with ketamine and chlorpromazine by means of 60 min of segmental hepatic ischemia followed by 120 min of reperfusion. At the onset of reperfusion, Group 1 (IRI + HES; n = 12) was given 13 mL·kg−1 of HES; Group 2 (IRI + HS; n = 12) received the same volume of 7.5% saline (HS), and Group 3 (IRI-only; n = 12) received no fluid. Three other groups of 12 animals each were sham-operated and received the same fluid as the test groups. We euthanized the animals after three hours, drew blood for alanine aminotransferase (ALT) quantification, and took ischemic liver samples for histomorphological study.

Results

Serum ALT activity was greater in all of the IRI groups than in the sham-operated animals. The ALT activity was 1,081 ± 575 IU·L−1 in IRI + HES Group 1; 2,363 ± 1,839 IU·L−1 in IRI + HS Group 2; and 2,866 ± 2,491 IU·L−1 in IRI-only Group 3. There was a statistically significant difference between the IRI + HES and the IRI-only groups (P = 0.001), but not between the IRI + HS and the IRI-only groups (P > 0.05). Likewise, histological scores were greater in all IRI groups compared with the sham-operated animals. Scores were higher in the IRI-only group (median 3.5) than in the groups receiving fluid (IRI + HES median 2; IRI + HS median 3). The difference between IRI + HES and IRI-only was statistically significant (P = 0.008) but not so between IRI + HS and IRI-only (P > 0.05).

Conclusions

Giving HES 130/0.4 attenuates rat liver IRI compared with no fluid, while giving HS does not. This suggests a role for HES in hepatoprotection associated with liver IRI.
Literatur
1.
Zurück zum Zitat Jaeschke H, Farhood A, Smith CW. Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J 1990; 4: 3355-9.PubMed Jaeschke H, Farhood A, Smith CW. Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J 1990; 4: 3355-9.PubMed
2.
Zurück zum Zitat Fondevila C, Busuttil RW, Kupiec-Weglinski JW. Hepatic ischemia/reperfusion injury - a fresh look. Exp Mol Pathol 2003; 74: 86-93.CrossRefPubMed Fondevila C, Busuttil RW, Kupiec-Weglinski JW. Hepatic ischemia/reperfusion injury - a fresh look. Exp Mol Pathol 2003; 74: 86-93.CrossRefPubMed
3.
Zurück zum Zitat Huguet C, Gavelli A, Bona S. Hepatic resection with ischemia of the liver exceeding one hour. J Am Coll Surg 1994; 178: 454-8.PubMed Huguet C, Gavelli A, Bona S. Hepatic resection with ischemia of the liver exceeding one hour. J Am Coll Surg 1994; 178: 454-8.PubMed
4.
Zurück zum Zitat Hilmi I, Horton CN, Planinsic RM, et al. The impact of postreperfusion syndrome on short-term patient and liver allograft outcome in patients undergoing orthotopic liver transplantation. Liver Transpl 2008; 14: 504-8.CrossRefPubMed Hilmi I, Horton CN, Planinsic RM, et al. The impact of postreperfusion syndrome on short-term patient and liver allograft outcome in patients undergoing orthotopic liver transplantation. Liver Transpl 2008; 14: 504-8.CrossRefPubMed
5.
Zurück zum Zitat Dart RC, Liebler DC, Sipes IG. Hepatic injury and lipid peroxidation during hemorrhagic shock and resuscitation. Life Sci 1993; 53: 1685-9.CrossRefPubMed Dart RC, Liebler DC, Sipes IG. Hepatic injury and lipid peroxidation during hemorrhagic shock and resuscitation. Life Sci 1993; 53: 1685-9.CrossRefPubMed
6.
Zurück zum Zitat Ke B, Lipshutz GS, Kupiec-Weglinski JW. Gene therapy in liver ischemia and reperfusion injury. Curr Pharm Des 2006; 12: 2969-75.CrossRefPubMed Ke B, Lipshutz GS, Kupiec-Weglinski JW. Gene therapy in liver ischemia and reperfusion injury. Curr Pharm Des 2006; 12: 2969-75.CrossRefPubMed
7.
Zurück zum Zitat Gallandat Huet RC, Siemons AW, Baus D, et al. A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery. Can J Anesth 2000; 47: 1207-15.CrossRefPubMed Gallandat Huet RC, Siemons AW, Baus D, et al. A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery. Can J Anesth 2000; 47: 1207-15.CrossRefPubMed
8.
Zurück zum Zitat Langeron O, Doelberg M, Ang ET, Bonnet F, Capdevila X, Coriat P. Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5. Anesth Analg 2001; 92: 855-62.CrossRefPubMed Langeron O, Doelberg M, Ang ET, Bonnet F, Capdevila X, Coriat P. Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5. Anesth Analg 2001; 92: 855-62.CrossRefPubMed
9.
Zurück zum Zitat Jungheinrich C, Scharpf R, Wargenau M, Bepperling F, Baron JF. The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%, 500 mL) in mild-to-severe renal impairment. Anesth Analg 2002; 95: 544-51.CrossRefPubMed Jungheinrich C, Scharpf R, Wargenau M, Bepperling F, Baron JF. The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%, 500 mL) in mild-to-severe renal impairment. Anesth Analg 2002; 95: 544-51.CrossRefPubMed
10.
Zurück zum Zitat Jungheinrich C, Neff TA. Pharmacokinetics of hydroxyethyl starch. Clin Pharmacokinet 2005; 44: 681-99.CrossRefPubMed Jungheinrich C, Neff TA. Pharmacokinetics of hydroxyethyl starch. Clin Pharmacokinet 2005; 44: 681-99.CrossRefPubMed
11.
Zurück zum Zitat Kozek-Langenecker SA. Effects of hydroxyethyl starch solutions on hemostasis. Anesthesiology 2005; 103: 654-60.CrossRefPubMed Kozek-Langenecker SA. Effects of hydroxyethyl starch solutions on hemostasis. Anesthesiology 2005; 103: 654-60.CrossRefPubMed
12.
Zurück zum Zitat Gandhi SD, Weiskopf RB, Jungheinrich C, et al. Volume replacement therapy during major orthopedic surgery using Voluven (hydroxyethyl starch 130/0.4) or hetastarch. Anesthesiology 2007; 106: 1120-7.CrossRefPubMed Gandhi SD, Weiskopf RB, Jungheinrich C, et al. Volume replacement therapy during major orthopedic surgery using Voluven (hydroxyethyl starch 130/0.4) or hetastarch. Anesthesiology 2007; 106: 1120-7.CrossRefPubMed
13.
Zurück zum Zitat Godet G, Lehot JJ, Janvier G, Steib A, De Castro V, Coriat P. Safety of HES 130/0.4 (Voluven(R)) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial. Eur J Anaesthesiol 2008; 25: 986-94.CrossRefPubMed Godet G, Lehot JJ, Janvier G, Steib A, De Castro V, Coriat P. Safety of HES 130/0.4 (Voluven(R)) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial. Eur J Anaesthesiol 2008; 25: 986-94.CrossRefPubMed
14.
Zurück zum Zitat Zikria BA, Subbarao C, Oz MC, et al. Macromolecules reduce abnormal microvascular permeability in rat limb ischemia/reperfusion injury. Crit Care Med 1989; 17: 1306-9.PubMed Zikria BA, Subbarao C, Oz MC, et al. Macromolecules reduce abnormal microvascular permeability in rat limb ischemia/reperfusion injury. Crit Care Med 1989; 17: 1306-9.PubMed
15.
Zurück zum Zitat Handrigan MT, Burns AR, Donnachie EM, Bowden RA. Hydroxyethyl starch inhibits neutrophil adhesion and transendothelial migration. Shock 2005; 24: 434-9.CrossRefPubMed Handrigan MT, Burns AR, Donnachie EM, Bowden RA. Hydroxyethyl starch inhibits neutrophil adhesion and transendothelial migration. Shock 2005; 24: 434-9.CrossRefPubMed
16.
Zurück zum Zitat Rittoo D, Gosling P, Simms MH, Smith SR, Vohra RK. The effects of hydroxyethyl starch compared with gelofusine on activated endothelium and the systemic inflammatory response following aortic aneurysm repair. Eur J Vasc Endovasc Surg 2005; 30: 520-4.CrossRefPubMed Rittoo D, Gosling P, Simms MH, Smith SR, Vohra RK. The effects of hydroxyethyl starch compared with gelofusine on activated endothelium and the systemic inflammatory response following aortic aneurysm repair. Eur J Vasc Endovasc Surg 2005; 30: 520-4.CrossRefPubMed
17.
Zurück zum Zitat Dieterich HJ, Weissmuller T, Rosenberger P, Eltzschig HK. Effect of hydroxyethyl starch on vascular leak syndrome and neutrophil accumulation during hypoxia. Crit Care Med 2006; 34: 1775-82.CrossRefPubMed Dieterich HJ, Weissmuller T, Rosenberger P, Eltzschig HK. Effect of hydroxyethyl starch on vascular leak syndrome and neutrophil accumulation during hypoxia. Crit Care Med 2006; 34: 1775-82.CrossRefPubMed
18.
Zurück zum Zitat Lang K, Suttner S, Boldt J, Kumle B, Nagel D. Volume replacement with HES 130/0.4 may reduce the inflammatory response in patients undergoing major abdominal surgery. Can J Anesth 2003; 50: 1009-16.CrossRefPubMed Lang K, Suttner S, Boldt J, Kumle B, Nagel D. Volume replacement with HES 130/0.4 may reduce the inflammatory response in patients undergoing major abdominal surgery. Can J Anesth 2003; 50: 1009-16.CrossRefPubMed
19.
Zurück zum Zitat Westphal M, James MF, Kozek-Langenecker S, Stocker R, Guidet B, Van Aken H. Hydroxyethyl starches: different products–different effects. Anesthesiology 2009; 111: 187-202.CrossRefPubMed Westphal M, James MF, Kozek-Langenecker S, Stocker R, Guidet B, Van Aken H. Hydroxyethyl starches: different products–different effects. Anesthesiology 2009; 111: 187-202.CrossRefPubMed
20.
Zurück zum Zitat Spiegel HU, Bahde R. Experimental models of temporary normothermic liver ischemia. J Invest Surg 2006; 19: 113-23.CrossRefPubMed Spiegel HU, Bahde R. Experimental models of temporary normothermic liver ischemia. J Invest Surg 2006; 19: 113-23.CrossRefPubMed
21.
Zurück zum Zitat Kaplan N, Yagmurdur H, Kilinc K, Baltaci B, Tezel S. The protective effects of intravenous anesthetics and verapamil in gut ischemia/reperfusion-induced liver injury. Anesth Analg 2007; 105: 1371-8.CrossRefPubMed Kaplan N, Yagmurdur H, Kilinc K, Baltaci B, Tezel S. The protective effects of intravenous anesthetics and verapamil in gut ischemia/reperfusion-induced liver injury. Anesth Analg 2007; 105: 1371-8.CrossRefPubMed
22.
Zurück zum Zitat Omar R, Nomikos I, Piccorelli G, Savino J, Agarwal N. Prevention of postischaemic lipid peroxidation and liver cell injury by iron chelation. Gut 1989; 30(4): 510–4.CrossRefPubMed Omar R, Nomikos I, Piccorelli G, Savino J, Agarwal N. Prevention of postischaemic lipid peroxidation and liver cell injury by iron chelation. Gut 1989; 30(4): 510–4.CrossRefPubMed
23.
Zurück zum Zitat Cheng XD, Jiang XC, Liu YB, Peng CH, Xu B, Peng SY. Effect of ischemic preconditioning on P-selectin expression in hepatocytes of rats with cirrhotic ischemia-reperfusion injury. World J Gastroenterol 2003; 9: 2289-92.PubMed Cheng XD, Jiang XC, Liu YB, Peng CH, Xu B, Peng SY. Effect of ischemic preconditioning on P-selectin expression in hepatocytes of rats with cirrhotic ischemia-reperfusion injury. World J Gastroenterol 2003; 9: 2289-92.PubMed
24.
Zurück zum Zitat Nascimento P Jr, de Paiva Filho O, de Carvalho LR, Braz JR. Early hemodynamic and renal effects of hemorrhagic shock resuscitation with lactated Ringer’s solution, hydroxyethyl starch, and hypertonic saline with or without 6% dextran-70. J Surg Res 2006; 136: 98-105.CrossRefPubMed Nascimento P Jr, de Paiva Filho O, de Carvalho LR, Braz JR. Early hemodynamic and renal effects of hemorrhagic shock resuscitation with lactated Ringer’s solution, hydroxyethyl starch, and hypertonic saline with or without 6% dextran-70. J Surg Res 2006; 136: 98-105.CrossRefPubMed
25.
Zurück zum Zitat Standl T, Burmeister MA, Schroeder F, et al. Hydroxyethylstarch (HES) 130/0.4 provides larger and faster increases in tissue oxygen tension in comparison with prehemodilution values than HES 70/0.5 or HES 200/0.5 in volunteers undergoing acute normovolemic hemodilution. Anesth Analg 2003; 96: 936-43.CrossRefPubMed Standl T, Burmeister MA, Schroeder F, et al. Hydroxyethylstarch (HES) 130/0.4 provides larger and faster increases in tissue oxygen tension in comparison with prehemodilution values than HES 70/0.5 or HES 200/0.5 in volunteers undergoing acute normovolemic hemodilution. Anesth Analg 2003; 96: 936-43.CrossRefPubMed
26.
Zurück zum Zitat Paul M, Dueck M, Joachim Herrmann H, Holzki J. A randomized controlled study of fluid management in infants and toddlers during surgery: hydroxyethyl starch 6% (HES 70/0.5) vs lactated Ringer’s solution. Paediatr Anaesth 2003; 13: 603-8.CrossRefPubMed Paul M, Dueck M, Joachim Herrmann H, Holzki J. A randomized controlled study of fluid management in infants and toddlers during surgery: hydroxyethyl starch 6% (HES 70/0.5) vs lactated Ringer’s solution. Paediatr Anaesth 2003; 13: 603-8.CrossRefPubMed
27.
Zurück zum Zitat Woessner R, Grauer MT, Dieterich HJ, et al. Influence of a long-term, high-dose volume therapy with 6% hydroxyethyl starch 130/0.4 or crystalloid solution on hemodynamics, rheology and hemostasis in patients with acute ischemic stroke. Results of a randomized, placebo-controlled, double-blind study. Pathophysiol Haemost Thromb 2003; 33: 121-6.CrossRefPubMed Woessner R, Grauer MT, Dieterich HJ, et al. Influence of a long-term, high-dose volume therapy with 6% hydroxyethyl starch 130/0.4 or crystalloid solution on hemodynamics, rheology and hemostasis in patients with acute ischemic stroke. Results of a randomized, placebo-controlled, double-blind study. Pathophysiol Haemost Thromb 2003; 33: 121-6.CrossRefPubMed
28.
Zurück zum Zitat Ando Y, Terao Y, Fukusaki M, et al. Influence of low-molecular-weight hydroxyethyl starch on microvascular permeability in patients undergoing abdominal surgery: comparison with crystalloid. J Anesth 2008; 22: 391-6.CrossRefPubMed Ando Y, Terao Y, Fukusaki M, et al. Influence of low-molecular-weight hydroxyethyl starch on microvascular permeability in patients undergoing abdominal surgery: comparison with crystalloid. J Anesth 2008; 22: 391-6.CrossRefPubMed
29.
Zurück zum Zitat Neff TA, Fischler L, Mark M, Stocker R, Reinhart WH. The influence of two different hydroxyethyl starch solutions (6% HES 130/0.4 and 200/0.5) on blood viscosity. Anesth Analg 2005; 100: 1773-80.CrossRefPubMed Neff TA, Fischler L, Mark M, Stocker R, Reinhart WH. The influence of two different hydroxyethyl starch solutions (6% HES 130/0.4 and 200/0.5) on blood viscosity. Anesth Analg 2005; 100: 1773-80.CrossRefPubMed
30.
Zurück zum Zitat Xiong L, Lei C, Wang Q, Li W. Acute normovolaemic haemodilution with a novel hydroxyethyl starch (130/0.4) reduces focal cerebral ischaemic injury in rats. Eur J Anaesthesiol 2008; 25: 581-8.CrossRefPubMed Xiong L, Lei C, Wang Q, Li W. Acute normovolaemic haemodilution with a novel hydroxyethyl starch (130/0.4) reduces focal cerebral ischaemic injury in rats. Eur J Anaesthesiol 2008; 25: 581-8.CrossRefPubMed
31.
Zurück zum Zitat Zhou DC, Ma XX, Xie JR, Luo F, Jin M. Protective effects of hydroxyethyl starch (130/0.4) against ischemia reperfusion injury of kidney: experiment with rats (Chinese). Zhonghua Yi Xue Za Zhi 2007; 87: 3224-7.PubMed Zhou DC, Ma XX, Xie JR, Luo F, Jin M. Protective effects of hydroxyethyl starch (130/0.4) against ischemia reperfusion injury of kidney: experiment with rats (Chinese). Zhonghua Yi Xue Za Zhi 2007; 87: 3224-7.PubMed
32.
Zurück zum Zitat Mukhtar A, Aboulfetouh F, Obayah G, et al. The safety of modern hydroxyethyl starch in living donor liver transplantation: a comparison with human albumin. Anesth Analg 2009; 109: 924-30.CrossRefPubMed Mukhtar A, Aboulfetouh F, Obayah G, et al. The safety of modern hydroxyethyl starch in living donor liver transplantation: a comparison with human albumin. Anesth Analg 2009; 109: 924-30.CrossRefPubMed
33.
Zurück zum Zitat Hanart C, Khalife M, De Ville A, Otte F, De Hert S. Van der Linden P. Perioperative volume replacement in children undergoing cardiac surgery: albumin versus hydroxyethyl starch 130/0.4. Crit Care Med 2009; 37: 696-701.CrossRefPubMed Hanart C, Khalife M, De Ville A, Otte F, De Hert S. Van der Linden P. Perioperative volume replacement in children undergoing cardiac surgery: albumin versus hydroxyethyl starch 130/0.4. Crit Care Med 2009; 37: 696-701.CrossRefPubMed
34.
Zurück zum Zitat Kramer GC. Hypertonic resuscitation: physiologic mechanisms and recommendations for trauma care. J Trauma 2003; 54(5 Suppl): S89-99.PubMed Kramer GC. Hypertonic resuscitation: physiologic mechanisms and recommendations for trauma care. J Trauma 2003; 54(5 Suppl): S89-99.PubMed
35.
Zurück zum Zitat Meyer PG, Orliaguet GA, Zerah M, et al. Emergency management of deeply comatose children with acute rupture of cerebral arteriovenous malformations. Can J Anesth 2000; 47: 758-66.CrossRefPubMed Meyer PG, Orliaguet GA, Zerah M, et al. Emergency management of deeply comatose children with acute rupture of cerebral arteriovenous malformations. Can J Anesth 2000; 47: 758-66.CrossRefPubMed
36.
Zurück zum Zitat Strandvik GF. Hypertonic saline in critical care: a review of the literature and guidelines for use in hypotensive states and raised intracranial pressure. Anaesthesia 2009; 64: 990-1003.CrossRefPubMed Strandvik GF. Hypertonic saline in critical care: a review of the literature and guidelines for use in hypotensive states and raised intracranial pressure. Anaesthesia 2009; 64: 990-1003.CrossRefPubMed
Metadaten
Titel
Hydroxyethyl starch 130/0.4 attenuates early hepatic damage in ischemia/reperfusion injury
verfasst von
Dora Catré, MS
Joaquim S. Viana, PhD
António M. Cabrita, PhD
Manuel Oliveira, MB
Andreia Felizes, MS
Maria F. Lopes, PhD
Publikationsdatum
01.05.2010
Verlag
Springer-Verlag
Erschienen in
Canadian Journal of Anesthesia/Journal canadien d'anesthésie / Ausgabe 5/2010
Print ISSN: 0832-610X
Elektronische ISSN: 1496-8975
DOI
https://doi.org/10.1007/s12630-010-9282-8

Weitere Artikel der Ausgabe 5/2010

Canadian Journal of Anesthesia/Journal canadien d'anesthésie 5/2010 Zur Ausgabe

Tipps für den Umgang mit Behandlungsfehlern

01.05.2024 DGIM 2024 Kongressbericht

Es ist nur eine Frage der Zeit, bis es zu einem Zwischenfall kommt und ein Behandlungsfehler passiert. Doch wenn Ärztinnen und Ärzte gut vorbereitet sind, schaffen es alle Beteiligten den Umständen entsprechend gut durch diese Krise. 

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.